Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Mar 21, 2025; 31(11): 102387
Published online Mar 21, 2025. doi: 10.3748/wjg.v31.i11.102387
Table 2 Univariate and multivariate logistic regression analysis of colorectal polyp recurrence 1 year after Endoscopic mucosal resection
Variables
Univariable analysis
Multivariable analysis
OR (95%CI)
P value
OR (95%CI)
P value
Age1.04 (1.03-1.05)< 0.001a1.05 (1.03-1.06)< 0.001a
Gender (%)
    FemaleReference-Reference-
    Male1.73 (1.37-2.19)< 0.001a0.94 (0.69-1.27)0.684
BMI1.07 (1.03-1.11)< 0.001a1.05 (1-1.1)0.056
Hypertension (%)
    NoReference-Reference-
    Yes1.75 (1.31-2.33)< 0.001a1.07 (0.75-1.52)0.722
Diabetes (%)
    NoReference-Reference-
    Yes1.42 (0.98-2.08)0.067--
CHD (%)
    NoReference-Reference-
    Yes2.33 (1.34-4.04)0.003a1.41 (0.73-2.72)0.300
Family history (%)
    NoReference-Reference-
    Yes10.07 (4.84-20.96)< 0.001a11.34 (5.09-25.26)< 0.001a
Cigarette preference (%)
    NoReference-Reference-
    Yes5.14 (3.5-7.54)< 0.001a3.92 (2.50-6.14)< 0.001a
Alcohol preference (%)
    NoReference-Reference-
    Yes1.34 (0.99-1.82)0.056--
Constipation (%)
    NoReference-Reference-
    Yes1.05 (0.69-1.58)0.831--
Diarrhea (%)
    NoReference-Reference-
    Yes1.40 (1.06-1.85)0.018a1.42 (1.02-1.99)0.038a
Hemafecia (%)
    NoReference-Reference-
    Yes1.24 (0.76-2.00)0.389--
Anatomical location (%)
    Proximal colonReference-Reference-
    Distal colon1.08 (0.80-1.45)0.6301.09 (0.77-1.05)0.635
    Total colon2.16 (1.57-2.96)< 0.001a0.92 (0.60-1.40)0.683
Number of polyps (%)
    < 3Reference-Reference-
    ≥ 33.10 (2.43-3.96)< 0.001a1.54 (1.07-2.21)0.019a
Number of adenomas (%)
    0Reference-Reference-
    1-22.02 (1.55-2.63)< 0.001a0.44 (0.10-1.95)0.279
    ≥ 38.96 (6.00-13.38)< 0.001a1.01 (0.22-4.70)0.989
Size (%)
    < 0.5Reference-Reference-
    0.5-12.18 (1.69-2.81)< 0.001a2.05 (1.50-2.80)< 0.001a
    > 16.65 (4.25-10.43)< 0.001a3.98 (2.02-7.86)< 0.001a
Endoscopic classification (%)
    IReference-Reference-
    II1.40 (1.09-1.81)0.010a0.71 (0.50-1.02)0.066
    III-IV3.32 (2.35-4.68)< 0.001a0.60 (0.32-1.11)0.106
Hazard classification (%)
    Non-neoplastic polypsReference-Reference-
    Non-progressive adenoma2.47 (1.89-3.21)< 0.001a4.48 (1.02-19.73)0.048a
    Progressive adenoma6.07 (4.17-8.84)< 0.001a5.29 (1.07-26.20)0.041a
Concomitant gastric polyp (%)
    NoReference-Reference-
    Yes0.90 (0.71-1.15)0.397--
H. pylori (%)
    NoReference-Reference-
    Yes1.89 (1.49-2.4)< 0.001a1.82 (1.37-2.42)< 0.001a
Hyperlipidemia (%)
    NoReference-Reference-
    Yes1.48 (1.15-1.90)0.002a1.20 (0.87-1.64)0.263
Uric acid levels (%)
    NormalReference-Reference-
    Elevated2.08 (1.26-3.41)0.004a1.15 (0.63-2.09)0.646
    TBIL1.01 (1.00-1.04)0.259--
    TBA1.02 (0.99-1.05)0.298--
    hsCRP1.03 (0.98-1.06)0.164--
CEA (%)
    NormalReference-Reference-
    Elevated1.10 (0.56-2.16)0.773--
CA724 (%)
    NormalReference-Reference-
    Elevated0.96 (0.54-1.72)0.899--
CA199 (%)
    NormalReference-Reference-
    Elevated0.92 (0.42-2.00)0.824--
CA242 (%)
    NormalReference-Reference-
    Elevated0.60 (0.30-1.22)0.162--